2023 Q3 Form 10-Q Financial Statement

#000143462123000017 Filed on July 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $155.2M $182.5M
YoY Change -34.75% -30.34%
Cost Of Revenue $7.570M $9.302M
YoY Change -46.33% -36.17%
Gross Profit $69.07M $173.2M
YoY Change -25.14% 84.66%
Gross Profit Margin 44.51% 94.9%
Selling, General & Admin $123.6M $145.2M
YoY Change -42.88% -35.41%
% of Gross Profit 178.99% 83.87%
Research & Development $10.84M $10.60M
YoY Change -22.81% -25.96%
% of Gross Profit 15.69% 6.12%
Depreciation & Amortization $4.760M $6.666M
YoY Change -9.75% 36.15%
% of Gross Profit 6.89% 3.85%
Operating Expenses $134.5M $162.5M
YoY Change -41.65% -32.05%
Operating Profit -$33.99M $10.66M
YoY Change 82.99% -373.73%
Interest Expense -$7.097M -$6.940M
YoY Change 24.07% 2.59%
% of Operating Profit -65.11%
Other Income/Expense, Net -$110.9M $1.879M
YoY Change -7382.34% 561.62%
Pretax Income -$152.0M $112.0K
YoY Change 567.45% -101.08%
Income Tax -$3.534M $227.0K
% Of Pretax Income 202.68%
Net Earnings -$148.5M -$115.0K
YoY Change -6.44% -98.57%
Net Earnings / Revenue -95.67% -0.06%
Basic Earnings Per Share -$11.43 -$0.01
Diluted Earnings Per Share -$11.43 -$0.01
COMMON SHARES
Basic Shares Outstanding 12.97M shares 12.91M shares
Diluted Shares Outstanding 12.99M shares 12.92M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $175.6M $162.6M
YoY Change -38.51% -41.73%
Cash & Equivalents $175.6M $162.6M
Short-Term Investments
Other Short-Term Assets $13.26M $12.58M
YoY Change -53.62% -54.33%
Inventory
Prepaid Expenses
Receivables $64.33M $89.21M
Other Receivables $0.00 $0.00
Total Short-Term Assets $266.9M $264.4M
YoY Change -34.98% -37.35%
LONG-TERM ASSETS
Property, Plant & Equipment $54.20M $121.0M
YoY Change -16.42% 77.07%
Goodwill $381.5M $420.1M
YoY Change -9.19% 0.0%
Intangibles $52.30M $54.28M
YoY Change -18.52% -23.3%
Long-Term Investments $60.08M $173.1M
YoY Change -65.59% -0.82%
Other Assets $6.426M $6.182M
YoY Change 1.87% -7.63%
Total Long-Term Assets $618.1M $774.7M
YoY Change -22.72% -17.76%
TOTAL ASSETS
Total Short-Term Assets $266.9M $264.4M
Total Long-Term Assets $618.1M $774.7M
Total Assets $885.0M $1.039B
YoY Change -26.88% -23.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.560M $3.174M
YoY Change -65.96% -59.57%
Accrued Expenses $66.99M $66.75M
YoY Change -20.69% -29.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.500M $2.500M
YoY Change 0.64% 0.36%
Total Short-Term Liabilities $71.05M $79.88M
YoY Change -22.38% -24.12%
LONG-TERM LIABILITIES
Long-Term Debt $625.7M $625.2M
YoY Change -23.07% -23.12%
Other Long-Term Liabilities $253.0K $84.94M
YoY Change -9.96% 30674.28%
Total Long-Term Liabilities $626.0M $710.2M
YoY Change -23.06% -12.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.05M $79.88M
Total Long-Term Liabilities $626.0M $710.2M
Total Liabilities $782.4M $797.4M
YoY Change -22.06% -21.33%
SHAREHOLDERS EQUITY
Retained Earnings -$850.4M -$702.0M
YoY Change 20.65% 28.51%
Common Stock $1.219B $1.210B
YoY Change 3.54% 4.04%
Preferred Stock
YoY Change
Treasury Stock (at cost) $266.2M $266.2M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $102.6M $241.7M
YoY Change
Total Liabilities & Shareholders Equity $885.0M $1.039B
YoY Change -26.88% -23.82%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$148.5M -$115.0K
YoY Change -6.44% -98.57%
Depreciation, Depletion And Amortization $4.760M $6.666M
YoY Change -9.75% 36.15%
Cash From Operating Activities $18.47M $15.07M
YoY Change 80.55% 147.26%
INVESTING ACTIVITIES
Capital Expenditures $5.075M $2.401M
YoY Change -293.41% -183.34%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$5.075M -$2.401M
YoY Change 93.41% -44.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -485.0K -100.0K
YoY Change -58.65% -100.12%
NET CHANGE
Cash From Operating Activities 18.47M 15.07M
Cash From Investing Activities -5.075M -2.401M
Cash From Financing Activities -485.0K -100.0K
Net Change In Cash 12.91M 12.57M
YoY Change 100.68% -84.76%
FREE CASH FLOW
Cash From Operating Activities $18.47M $15.07M
Capital Expenditures $5.075M $2.401M
Free Cash Flow $13.39M $12.67M
YoY Change 4.2% 41.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
3558000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
135000 usd
us-gaap Restructuring Charges
RestructuringCharges
8012000 usd
us-gaap Restructuring Charges
RestructuringCharges
3760000 usd
CY2023Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-488000 usd
CY2022Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
7000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-500000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
34000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
175840000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
265819000 usd
us-gaap Costs And Expenses
CostsAndExpenses
389359000 usd
us-gaap Costs And Expenses
CostsAndExpenses
551935000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6613000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3896000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6398000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6834000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6940000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6765000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18089000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-14270000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
439000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
284000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2273000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
283000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
112000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10377000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13964000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20821000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
227000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2339000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
622000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1957000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-115000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8038000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8038000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13342000 usd
us-gaap Net Income Loss
NetIncomeLoss
13342000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18864000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18864000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12915000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12723000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12881000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12812000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12915000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12723000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12912000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12812000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.47
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.47
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162641000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298845000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
34000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
124000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2609000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2317000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75710000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83060000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26045000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26250000 usd
CY2023Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5689000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
264430000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
413968000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35865000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33851000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56549000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59160000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
64415000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
67050000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
420139000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
420139000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
54284000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58315000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
173140000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
174580000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6182000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6101000 usd
CY2023Q2 us-gaap Assets
Assets
1039139000 usd
CY2022Q4 us-gaap Assets
Assets
1199313000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000 usd
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3174000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2030000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
74204000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75095000 usd
CY2023Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2909000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
79878000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82534000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
625240000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
813516000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84599000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88232000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7369000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6783000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
338000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
308000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
797424000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
991373000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16323675 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16167184 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12968209 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12811718 shares
CY2023Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
163000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
162000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1209687000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1189255000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-701957000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-715299000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3355466 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3355466 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
266178000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
266178000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1039139000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1199313000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13457000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
230979000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-115000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10199000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
652000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447992000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10826000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10826000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15080000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
43009000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3086000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
340848000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8038000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8038000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17335000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
341000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
350486000 usd
us-gaap Net Income Loss
NetIncomeLoss
13342000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18864000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5167000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3427000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4031000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14992000 usd
us-gaap Depreciation
Depreciation
9479000 usd
us-gaap Depreciation
Depreciation
9750000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21473000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
32415000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
586000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2026000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1894000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2029000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2736000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4454000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2373000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1475000 usd
tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-1923000 usd
tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-333000 usd
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
34308000 usd
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1440000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6809000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19812000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-280000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5593000 usd
tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
-4337000 usd
tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
-5226000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-227000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-293000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
591000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
302000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28224000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16093000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4853000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6346000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16440000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4853000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22786000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
250000000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1250000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-1042000 usd
tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-2745000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
43009000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1079000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-159665000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34584000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-136294000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27891000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298969000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
251342000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
162675000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279233000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000 usd
CY2023Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-900000 usd
CY2022Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates underlying the accompanying consolidated financial statements include: the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business combination; litigation accruals; contract assets; various other allowances, reserves and accruals; assumptions related to the determination of stock-based compensation; and the determination of right-of-use assets and lease liabilities. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the impact of the current economic conditions, including interest rates, inflation, and the COVID-19 pandemic on the assumptions and estimates used when preparing its consolidated financial statements including, but not limited to, the allowance for doubtful accounts, valuation allowances, contract asset, and the recoverability of long-lived assets, goodwill and intangible assets. These assumptions and estimates may change as new events occur and additional </span></div>information is obtained. If economic conditions worsen, such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Risks and Concentrations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and credit card fraud.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk at June 30, 2023, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which, in the event of non-payment, would be applied against any accounts receivable outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States.</span></div>
CY2023Q2 us-gaap Revenues
Revenues
182453000 usd
CY2022Q2 us-gaap Revenues
Revenues
261923000 usd
us-gaap Revenues
Revenues
382961000 usd
us-gaap Revenues
Revenues
545101000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
13500000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12200000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
900000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
931000 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1179000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1894000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162641000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298845000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
34000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
124000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2688000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1803000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2317000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1456000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2029000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1010000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
682000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1973000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1185000 usd
CY2023Q2 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
CY2022Q2 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
371000 usd
tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2609000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2300000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
483088000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
483088000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
420139000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
420139000 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44142000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48173000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
54284000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58315000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
86400000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42258000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44142000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
87400000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39227000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48173000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3664000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5889000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5830000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5504000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5198000 usd
CY2023Q2 tree Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
18057000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44142000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4200000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2100000 usd
CY2023Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
1700000 usd
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
400000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1400000 usd
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q2 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
35294000 usd
CY2022Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
37703000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10497000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11444000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1387000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1393000 usd
CY2023Q2 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7459000 usd
CY2022Q4 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7273000 usd
CY2023Q2 tree Charitable Contribution Accrual
CharitableContributionAccrual
0 usd
CY2022Q4 tree Charitable Contribution Accrual
CharitableContributionAccrual
500000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8777000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8513000 usd
CY2023Q2 tree Accrued Restructuring And Severance Current
AccruedRestructuringAndSeveranceCurrent
2608000 usd
CY2022Q4 tree Accrued Restructuring And Severance Current
AccruedRestructuringAndSeveranceCurrent
304000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
379895 shares
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
96700000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32415000 usd
CY2023Q2 us-gaap Share Price
SharePrice
22.11
CY2023Q2 us-gaap Share Price
SharePrice
22.11
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
227000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2339000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
622000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1957000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.027
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.225
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.045
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.094
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
400000 usd
tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
2900000 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q2 tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
227000 usd
CY2022Q2 tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
-2777000 usd
tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
622000 usd
tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
-4863000 usd
CY2023Q2 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
0 usd
CY2022Q2 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
438000 usd
tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
0 usd
tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
2906000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
227000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2339000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
622000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1957000 usd
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2023Q2 us-gaap Litigation Reserve
LitigationReserve
600000 usd
CY2022Q4 us-gaap Litigation Reserve
LitigationReserve
100000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023Q2 us-gaap Revenues
Revenues
182453000 usd
CY2023Q2 us-gaap Marketing Expense
MarketingExpense
103944000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
78509000 usd
CY2023Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
9302000 usd
CY2023Q2 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
12121000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29160000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10601000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4684000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1982000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
3558000 usd
CY2023Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-488000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6613000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6940000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
439000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
112000 usd
CY2022Q2 us-gaap Revenues
Revenues
261923000 usd
CY2022Q2 us-gaap Marketing Expense
MarketingExpense
168158000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
93765000 usd
CY2022Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
14574000 usd
CY2022Q2 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
16379000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40291000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14318000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4896000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7075000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
135000 usd
CY2022Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
7000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3896000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6765000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
284000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10377000 usd
us-gaap Revenues
Revenues
382961000 usd
us-gaap Marketing Expense
MarketingExpense
224495000 usd
us-gaap Gross Profit
GrossProfit
158466000 usd
us-gaap Cost Of Revenue
CostOfRevenue
23062000 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
28681000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
65843000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25256000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9479000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4031000 usd
us-gaap Restructuring Charges
RestructuringCharges
8012000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-500000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6398000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18089000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2273000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13964000 usd
us-gaap Revenues
Revenues
545101000 usd
us-gaap Marketing Expense
MarketingExpense
351872000 usd
us-gaap Gross Profit
GrossProfit
193229000 usd
us-gaap Cost Of Revenue
CostOfRevenue
30135000 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
36822000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76268000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28370000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9750000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14992000 usd
us-gaap Restructuring Charges
RestructuringCharges
3760000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
34000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6834000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-14270000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
283000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20821000 usd
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001434621-23-000017-index-headers.html Edgar Link pending
0001434621-23-000017-index.html Edgar Link pending
0001434621-23-000017.txt Edgar Link pending
0001434621-23-000017-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tree-20230630.htm Edgar Link pending
tree-20230630.xsd Edgar Link pending
tree-20230630_g1.jpg Edgar Link pending
tree-20230630_g2.jpg Edgar Link pending
tree-2023630x10qexx101.htm Edgar Link pending
tree-2023630x10qexx102.htm Edgar Link pending
tree-2023630x10qexx103.htm Edgar Link pending
tree-2023630x10qexx311.htm Edgar Link pending
tree-2023630x10qexx312.htm Edgar Link pending
tree-2023630x10qexx321.htm Edgar Link pending
tree-2023630x10qexx322.htm Edgar Link pending
tree-20230630_def.xml Edgar Link unprocessable
tree-20230630_lab.xml Edgar Link unprocessable
tree-20230630_pre.xml Edgar Link unprocessable
tree-20230630_htm.xml Edgar Link completed
tree-20230630_cal.xml Edgar Link unprocessable